- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05442073
Effect of Initial Empirical PEEP Setting on the Esophageal Pressure-guided PEEP Titration in ARDS
June 28, 2022 updated by: Peking Union Medical College Hospital
Effect of Initial Empirical Positive End-Expiratory Pressure (PEEP) Setting on the Esophageal Pressure-guided PEEP Titration in Acute Respiratory Distress Syndrome
Esophageal manometry was used as surrogate of pleural pressure to titrate positive end-expiratory pressure (PEEP) in ARDS patients.
However, Absolute values of esophageal pressure (Pes) could be affected by the PEEP setting.
In moderate to severe ARDS patients, the end-expiratory Pes changed differently with PEEP adjustment.
and the esophageal phenotypes could be divided into type I and type II.
with Type I (ΔPes≥30%ΔPEEP)and Type II(ΔPes<30%ΔPEEP).
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
18
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Peking Union Medical College Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 86 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patients all the moderate to severe ARDS with P/F<200 no contraindication to esophageal catheter
Description
Inclusion Criteria:
- aged over 18 all the moderate to severe ARDS patients invasive mechanical ventilation
Exclusion Criteria:
- aged<18 contraindication to esophageal catheter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Type I: ΔPes≥30%ΔPEEP
|
adjusting PEEP about 3-5cmH2O (increase or decrease)
|
|
Type II: ΔPes<30%ΔPEEP
|
adjusting PEEP about 3-5cmH2O (increase or decrease)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the changes of esophageal pressure during the PEEP titration
Time Frame: March 1st to May 31st, 2022
|
March 1st to May 31st, 2022
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Shuyang Zhang, MD, Peking Union Medical College Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Actual)
May 31, 2022
Study Completion (Actual)
June 29, 2022
Study Registration Dates
First Submitted
June 28, 2022
First Submitted That Met QC Criteria
June 28, 2022
First Posted (Actual)
July 1, 2022
Study Record Updates
Last Update Posted (Actual)
July 1, 2022
Last Update Submitted That Met QC Criteria
June 28, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZS-2458
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ARDS, Human
-
Bicetre HospitalUnknown
-
Biozeus Biopharmaceutical S.A.InCor Heart InstituteTerminatedPulmonary Disease | ARDS | ARDS, HumanBrazil
-
Implicit BioscienceNo longer availableCOVID | SARS-CoV2 | ARDS, Human | ArdsItaly
-
Guy's and St Thomas' NHS Foundation TrustRecruiting
-
University Hospital, Clermont-FerrandAZUREA groupCompleted
-
West China HospitalCompleted
-
Pamukkale UniversityCompleted
-
Southeast University, ChinaActive, not recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Hamilton Medical AGTerminated
-
Southeast University, ChinaUnknown
Clinical Trials on PEEP adjustment
-
Pontificia Universidad Catolica de ChileClínica Universidad de los AndesRecruitingRespiratory Failure | Mechanical Ventilation | EffortChile
-
Life UniversityCompleted
-
Life UniversityCompletedBrain FunctionUnited States
-
Gachon University Gil Medical CenterCompletedThe Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy (lapaPEEP)Brain IschemiaKorea, Republic of
-
Al-Azhar UniversityCompletedPulmonary Atelectasis, PostoperativeEgypt
-
Hongpeng LiCompletedTraumatic Brain Injury | Mechanical Ventilation Complication
-
Ankara City Hospital BilkentNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications | Impaired Oxygenation
-
Life UniversityUniversity of GeorgiaCompletedCognition - OtherUnited States
-
University Hospital, Basel, SwitzerlandRecruiting
-
Konkuk University Medical CenterUnknownValvular Heart Disease